Refine
Has Fulltext
- yes (18)
Is part of the Bibliography
- yes (18)
Year of publication
Document Type
- Journal article (18)
Language
- English (18)
Keywords
- 3D tissue model (2)
- Hirschsprung disease (2)
- blood-brain barrier (BBB) model (2)
- gene expression (2)
- rat (2)
- stem cells (2)
- Cell replacement therapy (1)
- Enteric nervous system (1)
- Enteric neuropathies (1)
- GUT (1)
Institute
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (17)
- Institut für Molekulare Infektionsbiologie (4)
- Theodor-Boveri-Institut für Biowissenschaften (4)
- Frauenklinik und Poliklinik (2)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Institut für Anatomie und Zellbiologie (1)
- Institut für Funktionsmaterialien und Biofabrikation (1)
- Institut für Hygiene und Mikrobiologie (1)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (1)
- Physikalisches Institut (1)
EU-Project number / Contract (GA) number
- 678119 (1)
Over the last 20 years, there has been increasing focus on the development of novel stem cell based therapies for the treatment of disorders and diseases affecting the enteric nervous system (ENS) of the gastrointestinal tract (so-called enteric neuropathies). Here, the idea is that ENS progenitor/stem cells could be transplanted into the gut wall to replace the damaged or absent neurons and glia of the ENS. This White Paper sets out experts' views on the commonly used methods and approaches to identify, isolate, purify, expand and optimize ENS stem cells, transplant them into the bowel, and assess transplant success, including restoration of gut function. We also highlight obstacles that must be overcome in order to progress from successful preclinical studies in animal models to ENS stem cell therapies in the clinic.